A Clinical Trial Coordinator plays a central role in the planning and execution of clinical research studies by ensuring that each trial runs smoothly, ethically, and in compliance with regulatory requirements. Their responsibilities include coordinating trial logistics, managing participant schedules, maintaining accurate study documentation, and supporting data collection processes. They act as a point of contact between sponsors, investigators, regulatory bodies, and clinical site staff to ensure consistent communication and timely progress throughout the trial.
In addition to administrative and regulatory duties, Clinical Trial Coordinators are actively involved in participant care, from screening and enrollment to follow-up. They are responsible for ensuring that informed consent is obtained and that study participants are treated according to the trial protocol. They help prepare for site audits and inspections, assist with adverse event reporting, and support data integrity efforts by ensuring timely and accurate data entry. Their in-depth understanding of clinical research guidelines, such as Good Clinical Practice (GCP), allows them to maintain compliance and high ethical standards throughout the trial. They must also manage multiple priorities under tight deadlines and adapt quickly to evolving study needs. Their contribution ensures trials not only meet scientific objectives but also protect participant safety and trust. By balancing clinical, regulatory, and operational tasks, they ensure that each study contributes valid and valuable results to medical research.
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami School of Medicine, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Tailored cellular environments to enable drug design
Lan Wang, Paretor LLC, United States
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : A NAMs-compatible mechanopharmacological model of drug penetration in the urinary bladder
Kunal Sharma, Swisss Federal Institute of Technology Lausanne, Switzerland
Title : Application of quality by design for pulmonary liposomes: Preliminary study to nano in-microparticle
Lucas Amaral Machado, University of Sao Paulo State – UNESP, Brazil
Title : Integrated Raman, SERS and computational approaches for the study of bioactive molecules in pharmaceutical chemistry
Maria Cristina Gamberini, University of Modena and Reggio Emilia, Italy
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, University of Alberta, Canada